| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0032 | 0.9 |